It is known that peripheral blood eosinophilia (PBE) is a normal hematopoietic response to several parasitic diseases, but it is less known that PBE promotes a hypercoagulable state that may favor thrombosis. Scope of this article is to explore which parasitic infestations are most likely to be complicated by thrombosis and to highlight the pathogenetic contribution of PBE to vascular occlusions in this setting. A review of the world literature revealed 18 cases in which PBE was associated with vascular occlusion though no specific surveys were dedicated to this topic. The eosinophil exerts its thrombogenic potential by inhibition of the natural anticoagulant pathways and release of tissue factor with enhanced coagulation activation leading to vascular occlusion. It is hoped that this review contributes to the awareness of the link between PBE and thrombosis in parasitic disorders to foster research in this area.
Introduction
Peripheral blood eosinophilia (PBE) is a common response to tissue invasion by parasites, 1 and vascular damage/occlusions are not uncommon during parasitic manifestations. 2 Nematodes in particular may travel through and occlude blood vessels as part of their life cycle in obligate and accidental hosts (humans), 2 but there are instances where vascular occlusions occur at sites distant from the parasitized areas. Aim of this overview is to describe such cases and provide a pathogenic explanation for the occurrence of vascular occlusions that may develop in the course of human parasitic infestations associated with PBE.
Methods
A Pubmed, Embase, and Google search of series and cases where vessel occlusions have been described in parasitic infestations, from 1970 to date, was performed. Search terms were thrombosis, stroke, infarction, vessel occlusion, portal, mesenteric, vein, Budd-Chiari, coagulation, eosinophil, protozoa, amoebae, flagellates, ciliates, coccidiae, nematodes, filariae, cestodes, and trematodes. Cases of thrombosis appearing in series or in single reports dealing with parasitic infestations where PBE could not be assigned to the individual patient were not considered for this overview. The emphasis is on the pathogenesis of thrombosis induced by eosinophil-derived molecules alongside specific prothrombotic factors induced by specific parasites.
Results
We found a total of 18 case reports dealing with PBE and thrombosis in the course of a parasitic disease. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] In 3 cases, occlusions were caused directly by the invading parasite; Ascaris lumbricoides occluded pulmonary and mesenteric artery in 2 cases, 17, 18 Echinococcus multilocularis cysts induced a Budd-Chiari syndrome by mass effect. 19 These 3 cases are not reported in Table 1 . Because we found only 1 study giving a prevalence figure for thrombosis in the course of parasitic infestations with PBE (acute trichinosis, 193 cases, 179 [93%] with PBE, of which 4 [2%] with unspecified thrombosis), 20 for each report detailing a case of thrombosis in association with PBE secondary to a parasitic disease, we identified (where possible) a survey showing the frequency of PBE in that parasitic infestation [21] [22] [23] [24] [25] [26] (Table 1 ). In this way, there is an idea of the frequency of thrombosis in the infestation with PBE.
Clinical Evidence for Vascular Occlusions in Parasitic Diseases
Nematodes. With regard to filariasis, Wuchereria Bancrofti microfilariae were detected in the peripheral blood of a 28-year-old Indian male presenting with right-hand side hemiparesis and mild motor dysphasia secondary to left frontal lobe infarction. 3 
An 11-year-old boy infested with Mansonella
Perstans underwent a mitral valve replacement for severe regurgitation, but the persistence of PBE in the postoperative period caused thrombosis on the prosthetic valve despite adequate anticoagulation. However, a second valve was uneventfully inserted. 4 Occlusion of the ulnar veins occurred in 1 patient with loa loa. 5 In the case of tissue nematodes, thrombosis of small ileal vessels on the borders of perforated ileal segments occurred in 2 patients with Angiostrongyloides costaricensis. 6, 7 With regard to intestinal nematodes, occlusion of pulmonary veins and intrahepatic branches of the portal vein was detected at autopsy in a woman who had died of hemorrhagic stroke. Because of the presence of immunoglobulin E (IgE) antiascarid, it was felt that she had been parasitized with Ascaris lumbricoides. 8 With regard to tissue nematodes, ventricular thrombosis superimposed on mural endocarditis has been described in trichinosis 9 ; in this situation, cerebral infarction may soon follow heart involvement particularly when the PBE is greater than 4 Â 109/L. 10 A case of superior sagittal sinus occlusion and another case of isolated ischemic stroke have been reported in trichinosis. 11, 12 Multiple cerebral ischemic lesions on CT scan and an acute aortic occlusion developed in 2 patients with toxocara. 13, 14 Trematodes. Microembolic occlusion of multiple distal cerebral vessels developed in a patient infested with Schistosoma mansoni, who had endomyocardial fibrosis. 15 Other. An aorto-iliac occlusion developed during PBE associated with Giardia lamblia gastroenteritis. 16 
Pathogenesis of Thrombosis
Specific eosinophil factors. Eosinophils are equipped with a variety of granules containing specific molecules that may induce thrombosis and vascular damage. Major basic protein (MBP), eosinophilic cationic protein (ECP), and eosinophil peroxidase (EPO) are present in crystalloid granules, whereas Charcot-Leyden crystal protein is present in primary granules. 27 Major basic protein and ECP are strong basic proteins that can perturb the lipid bilayer and increase membrane permeability. 28 Eosinophil peroxidase is a peroxidase that in the presence of superoxide generated during the respiratory burst oxidizes halides to form hypohalous acids that are cytotoxic. 29, 30 Platelet activating factor (PAF) is a lipid mediator generated from a cytoplasmic enzyme after eosinophil stimulation and induces platelet, leukocyte, and endothelial cell activation. 31 Parasitized human and experimental animals show increased blood and tissues levels of activated eosinophils displaying upregulation of surface molecules, degranulation and enhanced cellular cytotoxicity, and cytokines and leukotrienes secretion 32, 33 in keeping with the release of the above factors. More recently, eosinophils have been demonstrated to store and express tissue factor, eventually activating the coagulation pathway via factor VII (FVII) and FX 34 (Figure 1 ).
Evidence for a prothrombotic pathway. In the late 1970s, MBP was reported to cause endothelial damage, 35 whereas ECP was felt to promote a hypercoagulable state by activating FXII. 36 Later, however, it was found that ECP inhibited FXII activation induced by ellagic acid and sulfatides, negatively charged activators of FXII. 37 Because of its cationic nature, the inhibitory effect of ECP on FXII was explained by neutralization of the negative charges of ellagic acid and sulfatides. The inhibitory effect was also shared by EPO and MBP. In this way, FXII-derived fragments that normally activate fibrinolysis are no longer produced and the fibrinolytic potential may decrease 38, 39 favoring thrombosis. 40 It was subsequently demonstrated that ECP neutralized negatively charged heparin, preventing the conformational change required for antithrombin to block thrombin. 41 Further in vitro studies demonstrated that MBP, EPO, and ECP bound anionic thrombomodulin and prevented thrombin-dependent activation of protein C. This phenomenon occurred both in endothelial cell monolayers and in fluid phase. 42 More specifically, MBP interfered with thrombin binding at the endothelial growth factor (EGF) domain of thrombomodulin, 43 resulting in a distorted conformation of the thrombin/thrombomodulin/protein C complex such that substrate specificity and/or affinity of thrombin shift away from protein C to fibrinogen. The overall effect would lead to unhindered thrombin generation and fibrin formation. Elevated levels of fibrinogen degradation products, indicating enhanced fibrin turnover, had been described in 31 patients with hypereosinophilia due to several causes including parasitic infections. 44 Plasma fibrinogen concentration was also elevated, probably due the background inflammatory nature of the disorders under study. Platelet adhesion and aggregation were normal in all patient groups, although platelet FIV and b-thromboglobulin, markers of in vivo platelet activation (in those years), were elevated in the patient groups. Platelet FIV binds to heparin and heparin-like molecules on the surface of endothelial cells with high affinity and can neutralize their anticoagulant effects, adding to the effect of ECP described above. 45 It was subsequently described that MBP and ECP induced a dose-dependent secretion of platelet 5-hydroxytripamine and a-granule components (that include platelet FIV) from platelet suspensions, behaving as strong platelet agonists. Indeed, plasma levels of PAF are elevated in patients with the hypereosinophilic syndrome. 46 
Discussion
The prothrombotic pathways described above may be enhanced (or depressed) according to the background cause of eosinophilia. In the case of filarial worms, serum tumor necrosis factor a (TNF-a) correlates with severity of the disease 47 as well as with elevated soluble intercellular adhesion molecule-1 and soluble E-selectin in human bancroftian filariasis but not in ascariasis nor in strongyloidiasis. 48 This indicates endothelial activation with a possible shift toward a proadhesive and prothrombotic phenotype. Conversely, excretory and/or secretory products of Brugia malayi can suppress endothelial activation and restore the endothelium to its antithrombotic and antiadhesive phenotype to allow for persistent parasitism. 49 With regard to flukes, advanced hepatosplenic schistosomiasis in endemic areas is associated with enhanced thrombin and plasmin generation, in keeping with low-grade disseminated intravascular coagulation; therefore, bleeding rather than thrombosis becomes the most serious and often life-threatening complication. 50 However, PBE may shift the balance toward excess thrombin generation with consequent thrombosis. A comparison of patients affected by schistosoma with different parasitemia intensities (according to fecal egg count) or with severe (hepatosplenic) or milder (intestinal) pathology revealed higher serum levels of sE-selectin in patients with intestinal disease than patients with hepatosplenic disease 51 suggesting endothelial activation. At variance, larval forms of Schistosoma mansoni can inhibit TNF-a-induced synthesis of E-selectin and vascular adhesion molecule-1 to escape immune adhesion/recognition 52 although recombinant TNF-b and, to a lesser extent, recombinant TNF-a may transform normal platelets into killer cells for the young schistosomal larvae. 53 Interestingly among flukes, fasciola hepatica secretes a cathepsin proteinase that cleaves fibrinogen and produces a fibrin clot. 54 It appears that different levels of parasitism may lead to differing degrees of endothelial activation that may add to the prothrombotic potential of the ECP/MBP/EPO driven pathway. The latter may generate occlusive events in both arterial and venous systems, though in the reported cases, thrombosis distant from the parasitized area seemed to prevail on the arterial side, particular in the cerebral vessels. Most of the vascular occlusions described occurred in nematode infestations likely due to their prevalent tissue parasitism. Interleukin 5 on its own is sufficient to recruit eosinophils in peripheral blood, whereas heparin that fails binding to antithrombin resulting thus in unhindered factor X activation and thrombin generation; C) MBP/ECP stimulate platelets to release PF4 that neutralizes heparan-sulphate and exogenous heparin as per point B above; D) MBP/ECP block thrombomodulin mediated PC activation with loss of the inhibitory effect of aPC on factor V and factor VIII; E) EPO stimulates endothelial cells to expose tissue factor that activates factor X via activation of factor VII; F) eosinophils store and release tissue factor. Abbreviations: MBP ¼ membrane basic protein; ECP ¼ eosinophil cationic protein; EPO ¼ eosinophil peroxidase; PF4: platelet factor 4; PC ¼ protein C; aPC ¼ activated protein C.
eosinophil infiltration into tissues relies on additional cytokines (interleukin 4 and interleukin 13) 55, 56 and chemokines (eg, Regulated upon Activation, NormalT-cell Expressed, and Secreted (RANTES) and eotaxin) released from immune effector cells stimulated by invading parasites. 57, 58 Eosinophil activation and secretion of thrombogenic factors may vary accordingly. Moreover, PBE is greater and more sustained in response to parasites whose development occurs during tissue migration (ascariasis, filariasis, trichinosis) compared to parasites that are exclusively intraluminal (tapeworms) or encapsulated in cystic structures (hydatid cysts). 59, 60 A similar reasoning could be applied to infestation with Giardia lamblia, as being a protozoan, it is not commonly associated with PBE, but PBE may develop in persistent tissue invasion. 61 In conclusion, vascular occlusions may develop in parasitic diseases characterized by PBE, but given the high frequency of PBE in such diseases, one would expect a greater occurrence of thrombosis. It is possible that limited knowledge of this association has hindered the setting up of adequate surveys looking at prevalence of thrombosis and defining a threshold level of PBE at which thrombosis might develop. A drawback of the reported cases is that inherited and acquired causes (antiphospholipid antibodies) for thrombophilia were not investigated as they might have contributed to the thrombotic risk. The hypereosinophilic syndrome strongly associates with thrombosis that may recur despite adequate heparin and warfarin anticoagulation. 62 In selected cases of PBE related to parasitic disease, the discerning clinician may consider thromboprophylaxis to reduce the morbidity and/or mortality linked to thrombosis in general and to ischemic stroke in particular.
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